# Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)

> **NCT01837381** · NA · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 200 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** TEA

## Key facts

- **NCT ID:** NCT01837381
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2019-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01837381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01837381, "Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01837381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*